Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
NCT00455832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2012-02-29
Summary
The aim of this study is to study the effect of peginterferon alpha and ribavirin on spermatozoa.
Conditions
- Sperm Motility (Focus of Study)
Interventions
- PROCEDURE
-
peginterferon alpha and ribavirin
sperm collection
Sponsors & Collaborators
- collaborator OTHER
-
Foundation for Liver Research
lead OTHER
Principal Investigators
-
Robert J de Knegt, MD PhD · Foundation for Liver Research
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
NCT00215865 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C
NCT01754974 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C
NCT00144469 ·Status: COMPLETED ·Phase: PHASE3
-
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
NCT00422838 ·Status: COMPLETED
-
Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients
NCT00085917 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
NCT02427204 ·Status: COMPLETED
-
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
NCT00154869 ·Status: UNKNOWN ·Phase: PHASE3
-
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
NCT00718172 ·Status: COMPLETED ·Phase: PHASE1
-
Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs
NCT00062816 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy
NCT01718158 ·Status: COMPLETED ·Phase: PHASE3
-
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
NCT00532701 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573 ·Status: COMPLETED
-
Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
NCT00543244 ·Status: UNKNOWN
-
A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)
NCT01280656 ·Status: COMPLETED
-
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
NCT01447394 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis
NCT01609049 ·Status: COMPLETED
-
Treatment of Hepatitis C in Hemophilic Patients With HIV
NCT00055341 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)
NCT00686517 ·Status: COMPLETED ·Phase: PHASE3
-
Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
NCT00086541 ·Status: COMPLETED ·Phase: PHASE3
-
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
NCT00630084 ·Status: COMPLETED ·Phase: PHASE4
-
Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders
NCT00624325 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
NCT01471574 ·Status: COMPLETED ·Phase: PHASE3
-
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
NCT01285050 ·Status: COMPLETED ·Phase: PHASE4
-
Ribavirin Dose Optimization for the Treatment of Hepatitis C
NCT01289496 ·Status: COMPLETED ·Phase: PHASE2
-
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
NCT00078403 ·Status: COMPLETED ·Phase: PHASE2